Paul J. Wyckoff
On January 6, 2025, Paul J. Wyckoff was appointed Cemtrex’s Chief Financial Officer
Highest-materiality recent filing
Cemtrex announces 1-for-15 reverse stock split effective June 5, 2026 to regain Nasdaq compliance
1-for-15 reverse split effective June 5, 2026 at 12:01 a.m. ET; symbol CETX unchanged; new CUSIP 15130G865.
Asset and facility purchase price $5.5M ($600K business + $4.9M real estate), financed via Fulton Bank loans.
Cemtrex raises $4M in registered direct offering of common stock and pre-funded warrants
Issued 400,000 shares and pre-funded warrants for 1,069,507 shares at $2.722/share to single institutional investor.
Cemtrex completes $7.06M cash acquisition of Invocon, launches Aerospace & Defense segment
Acquired 100% of Invocon for $7,060,000 cash; transaction closed January 8, 2026.
Cemtrex issues 4.76M shares to settle $6.1M debt and raise $5.5M via warrants
Issued 2,500,609 shares on Dec 8, 2025 to satisfy $6,084,000 of debt under exchange agreements.
Cemtrex closes $2M registered direct offering of common stock and pre-funded warrants
Issued 310,000 common shares and pre-funded warrants for 356,667 shares at $3/share.
Cemtrex agrees to acquire aerospace/defense firm Invocon for $7.06M
Purchase of 100% of Invocon for $7,060,000 in cash; net working capital adjustment with target NWC ≥ $500K.
Cemtrex issues $7.025M promissory note to Streeterville Capital; proceeds for acquisitions
Note of $7,025,000 issued to Streeterville Capital; net cash of $7,000,000 after $25k origination fee.
Cemtrex announces 1-for-15 reverse stock split to regain Nasdaq compliance
Reverse split at 1-for-15 effective September 29, 2025; symbol CETX unchanged.
Cemtrex regains Nasdaq compliance with $6.4M stockholders' equity
Nasdaq confirmed June 4, 2025 that Cemtrex meets minimum stockholders' equity requirement.
Cemtrex closes $1.25M public offering of 1.25M shares at $1.00/share
Offering of 1,250,000 shares at $1.00 per share for gross proceeds of $1.25 million.
Cemtrex gets Nasdaq extension to Aug 20, 2025 to regain minimum equity compliance
Nasdaq granted extension until Aug 20, 2025 to meet minimum $2.5M stockholders' equity requirement.
Cemtrex receives Nasdaq delisting notice for stockholders' equity below $2.5M
Stockholders' equity of $(1.56M) as of Dec 31, 2024, below Nasdaq's $2.5M minimum.
Cemtrex regains Nasdaq listing compliance with $4.71M equity
Received Nasdaq notice on Jan 2, 2025 confirming compliance with minimum stockholders' equity requirement.
Cemtrex approves 1-for-35 reverse stock split effective Nov 26 to regain Nasdaq compliance
Reverse split ratio of 1-for-35; effective at 12:01 a.m. ET on November 26, 2024; CUSIP changes to 15130G881.
Cemtrex gets Nasdaq extension to Feb 17, 2025 to cure equity deficiency
Nasdaq granted extension for minimum $2.5M stockholders' equity compliance.
Cemtrex announces 1-for-60 reverse stock split to regain Nasdaq compliance
Reverse stock split at 1-for-60 ratio effective Oct 3, 2024 at 12:01 a.m. ET.
Stockholders' equity of $47,956 on June 30, 2024 is well below Nasdaq's $2.5M minimum requirement.
Cemtrex receives Nasdaq delisting notice for bid price below $1.00 for 30 days
Received Nasdaq deficiency letter on June 14, 2024; bid price below $1.00 for 30 consecutive trading days.
Cemtrex closes public offering of units, raising ~$10.0M gross proceeds
Aggregate gross proceeds to company ~$10.0M from sale of 11,764,705 Units and 11,210,000 Pre-Funded Units.
Cemtrex signs standstill with Streeterville; must pay 50% of equity proceeds or $4M
Streeterville agrees to one-year redemption standstill on two notes ($5.755M Sep-2021 and $9.205M Feb-2022) conditional on at least $9M financing by May 10, 2024.
On January 6, 2025, Paul J. Wyckoff was appointed Cemtrex’s Chief Financial Officer
Max materiality 0.85 · Median 0.60 · Most common event other_material